US5903282094 - MACK - A2DW3Q (XNMS)
MERRIMACK PHARMACEUTICALS INC Acción
Sin cotización
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 15,06 % | 327,40 % |
Company Profile for MERRIMACK PHARMACEUTICALS INC Share
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Company Data for MERRIMACK PHARMACEUTICALS INC Share
Name MERRIMACK PHARMACEUTICALS INC
Company Merrimack Pharmaceuticals, Inc.
Symbol MACK
Website https://www.merrimack.com
Primary Exchange
NASDAQ/NMS (GLOBAL MARKET)
WKN A2DW3Q
ISIN US5903282094
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Gary L. Crocker M.B.A.
Market Capitalization 224 Mio
Country United States of America
Currency USD
Employees -
Address One Broadway, 02142 Cambridge
IPO Date 2012-03-29
Dividends from 'MERRIMACK PHARMACEUTICALS INC'
Ex-Date | Dividend per Share |
---|---|
20.05.2024 | 15,10 USD |
13.12.2019 | 0,50 USD |
06.09.2019 | 1,50 USD |
30.05.2017 | 1,06 USD |
Stock Splits
Date | Split |
---|---|
06.09.2019 | 1271:1000 |
06.09.2017 | 1:10 |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | MACK |
More Shares
Investors who MERRIMACK PHARMACEUTICALS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.